These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 18237464

  • 1. Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats.
    Nicolazzo JA, Nguyen TT, Katneni K, Steuten JA, Smith G, Jarrott B, Callaway JK, Charman SA.
    J Pharm Pharmacol; 2008 Feb; 60(2):171-8. PubMed ID: 18237464
    [Abstract] [Full Text] [Related]

  • 2. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR, Lewis RC, Phillips BA, Overmyer SK, Hatfield NZ, Narang PK.
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P, Naimi E, Sun WY, Knaus EE, Wiebe LI.
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
    Bhattaram VA, Paliwal JK, Gupta RC.
    Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
    Lal J, Gupta RC.
    Arzneimittelforschung; 2008 Mar; 58(2):62-70. PubMed ID: 18412019
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats.
    Tasso L, Neves G, Menegatti R, Fraga CA, Barreiro E, Eifler-Lima V, Rates SM, Costa TD.
    Eur J Pharm Sci; 2005 Oct; 26(2):194-202. PubMed ID: 16076552
    [Abstract] [Full Text] [Related]

  • 9. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M.
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
    Chu D, Liu W, Huang Z, Liu S, Fu X, Liu K.
    Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
    [Abstract] [Full Text] [Related]

  • 11. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z, Zadjura L, D'Arienzo C, Marino A, Santone K, Klunk L, Greene D, Lin PF, Colonno R, Wang T, Meanwell N, Hansel S.
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [Abstract] [Full Text] [Related]

  • 12. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
    Rivière GJ, Gentry WB, Owens SM.
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
    [Abstract] [Full Text] [Related]

  • 13. Blood and cerebral concentrations of the new potential analgesic UP 26-91 measured in vivo by microdialysis after toxic doses.
    Bouër R, Saivin S, Malmary MF, Hermann P, Poey J, Houin G.
    Arzneimittelforschung; 1998 Jul; 48(7):745-9. PubMed ID: 9706375
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of centperazine: a new antifilarial agent.
    Agarwal N, Sharma S, Srivastava VM.
    Int J Clin Pharmacol Res; 1988 Jul; 8(4):231-7. PubMed ID: 3182112
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype.
    Conrado DJ, Verli H, Neves G, Fraga CA, Barreiro EJ, Rates SM, Dalla Costa T.
    J Pharm Pharmacol; 2008 Jun; 60(6):699-707. PubMed ID: 18498705
    [Abstract] [Full Text] [Related]

  • 16. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence.
    Callaway JK, Castillo-Melendez M, Giardina SF, Krstew EK, Beart PM, Jarrott B.
    Neuropharmacology; 2004 Jul; 47(1):146-55. PubMed ID: 15165842
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
    Shayeganpour A, Hamdy DA, Brocks DR.
    Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
    [Abstract] [Full Text] [Related]

  • 18. Effect of dose and input rate on the brain penetration of BMS-204352 following intravenous administration to rats.
    Krishna R, Palme H, Zeng J, Srinivas N.
    Biopharm Drug Dispos; 2002 Sep; 23(6):227-31. PubMed ID: 12214322
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat.
    Teng XW, Davies NM, Fukuda C, Good RL, Fariss MW.
    Biopharm Drug Dispos; 2005 Jul; 26(5):195-203. PubMed ID: 15900617
    [Abstract] [Full Text] [Related]

  • 20. [Characteristics of pyrrolidone pharmacokinetics in rats].
    Sariev AK, Lun'shina EV, Zherdev VP.
    Eksp Klin Farmakol; 2003 Jul; 66(6):50-2. PubMed ID: 14743713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.